Clinical trial
Pfizer/IVGTT/Ziprasidone/Olanzapine
NCT00205725 · Washington University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00205725 |
|---|---|
| Title | Pfizer/IVGTT/Ziprasidone/Olanzapine |
| Official title | Glucose Regulation During Ziprasidone Treatment |
| Lead sponsor | Washington University School of Medicine, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Schizophrenia, Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Ziprasidone, Olanzapine |
| Enrollment | 120 |
| Start date | Nov 1, 2000 |
| Primary completion | Oct 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 13, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: